Top CDMO companies by revenue 2022

This statistic depicts the 2022 revenue of the world's leading contract development and manufacturing organizations. U.S.-based company Catalent had contract development and manufacturing revenues totaling some 4.3 billion U.S. dollars. A contract development and manufacturing organization (CDMO) is able to take over some parts of a pharmaceutical company, which could include any service from drug development to drug manufacturing.

Leading 10 contract development and manufacturing organizations (CDMOs) based on revenue in 2022 (in billion U.S. dollars)

Characteristic	Revenue in billion U.S. dollars
MilliporeSigma (Germany)	1.02
Boehringer Ingelheim (Germany)	1.1
Recipharm (Sweden)	1.31
Fujifilm Diosynth Biotechnologies (Japan)	1.31
Siegfried (Switzerland)	1.38
Samsung Biologics (South Korea)	1.77
WuXi Biologics (China)	2.11
Catalent (U.S.)	4.28
Thermo Fisher Scientific (U.S.)	6.97
Lonza Group (Switzerland)	6.97

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

September 2023

More information

Region

Worldwide

Survey time period

2022

Supplementary notes

All values are contract development and manufacturing revenues only. For companies with financial years other than calendar years, the last available revenue (as of August 2023) was taken.

Citation formats